What is the Apyx Medical Corp. stock price forecast?

Apyx Medical Corp. is currently trading at $4.15. View real-time AI analysis on Alpha Lenz.

What is Apyx Medical Corp. insider trading activity?

View the latest insider trading data for Apyx Medical Corp. on Alpha Lenz.

What is Apyx Medical Corp.'s P/E ratio?

Apyx Medical Corp.'s P/E ratio is -15.2.

Apyx Medical Corp.

NASDAQ · APYX

$4.15-0.45(-9.78%)Pre-market

Ask about Apyx Medical Corp.'s future dividend policy...

Alpha Chat Insight

“Apyx Medical Corp. trades at a P/E of -15.2 (undervalued) with modest ROE of -78.0%.”

Ask for details →

Company Overview

Apyx Medical Corp. is an advanced energy technology company, primarily focusing on the development and commercialization of helium plasma and radiofrequency technology products in the cosmetic and surgical markets. Its flagship product, the Renuvion Cosmetic Technology, leverages helium-derived plasma for precision surgical applications, providing enhanced safety and efficacy in procedures such as skin resurfacing and tissue contraction. Another product, the J-Plasma device, employs radiofrequency energy, targeting soft tissue procedures with minimal thermal damage. Founded in 1982, Apyx Medical Corp. has positioned itself as a leader in innovation within the aesthetic surgery sector, catering to medical professionals and specialists seeking cutting-edge, minimally invasive solutions. The company's continued commitment to research and development underpins its strategic growth in both domestic and international medical markets, reinforcing its significance as a pioneer in enhancing surgical outcomes.

CEOMr. Charles D. Goodwin II

Websitehttps://apyxmedical.com

SectorHealthcare

IndustryMedical Devices

Employees220

Company Statistics

FY 2025

Profile

$170.54MMarket Cap

$52.84MRevenue

0.00Shares Out

220Employees

Margins

62.53%Gross

-8.69%EBITDA

-12.20%Operating

-20.50%Pre-Tax

-21.01%Net

Valuation

-15.21P/E

11.73P/B

3.23EV/Sales

-38.87EV/EBITDA

-18.71P/FCF

Growth (CAGR)

5.89%Rev 3Yr

13.78%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-16.87%ROA

-77.99%ROE

-7.97%ROIC

Financial Health

$31.74MCash & Cash Equivalents

$20.27MNet Debt

350.68%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Apyx Medical Corp. trades at a P/E of -15.2 (undervalued) with modest ROE of -78.0%.”

Ask for details →

Frequently Asked Questions

Apyx Medical Corp. (ticker: APYX) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 220 employees. Market cap is $171M.

The current price is $4.15 with a P/E ratio of -15.21x and P/B of 11.73x.

ROE is -77.99% and operating margin is -12.20%. Annual revenue is $53M.